Gonadoblastoma
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
Drugs
(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide,
Adenovirus-associated vector containing human Fas-c gene,
Bevacizumab
(
Equidacent,
AVASTIN,
Aybintio,
MVASI
)
(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide,
Adenovirus-associated vector containing human Fas-c gene,
Bevacizumab
(
Equidacent,
AVASTIN,
Aybintio,
MVASI
),
Defactinib,
Maytansinoid-conjugated human monoclonal antibody against mesothelin,
Olaparib
(
LYNPARZA
),
Patupilone (Epothilone B),
Pyr-His-Trp-Ser-Tyr-D-Lys(doxorubicinylglutarate)-Leu-Arg-Pro-Gly-NH2, acetate salt,
Rucaparib
(
RUBRACA
),
Vaccine consisting of 5 survivin peptides with different human leukocyte antigen restrictions,
autologous dendritic cells pulsed with killed ovarian cancer cells and matured by TLR3 ligand ex vivo,
human reovirus type 3 Dearing strain,
humanised anti-folate receptor 1 monoclonal antibody conjugated to maytansinoid DM4
Registered!
Gonadoblastoma is a rare benign neoplasm of mixed sex cord and germ cells, arising mostly in the dysgenic gonads of young women with a chromosome Y anomaly, presenting with abdominal enlargement, variable feminization or virilization or, in some cases, being asymptomatic. It is often associated with dysgerminoma.